According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

In both trials, DOR/ISL met the primary efficacy success criterion for non-inferiority to comparator antiretroviral therapies and primary safety objective RAHWAY, N.J., March 12, 2025--Merck ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

Night - Partly cloudy. Winds SSW at 6 mph (9.7 kph). The overnight low will be 28 °F (-2.2 °C). Mostly cloudy with a high of 53 °F (11.7 °C). Winds S at 5 to 9 mph (8 to 14.5 kph). Partly ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

RAHWAY, N.J., March 12, 2025--Merck Announces Data from Phase 3 Trials that Show Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir Maintained HIV-1 Viral Suppression ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

As of 12:42:05 pm GMT-4. Market open. Loading Chart for MRK ...

Observations were drawn from Kuitpo Forest Reserve {station 023887}.